Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Briefly: Democrats winning on healthcare | Hospital pharmacies blinded by bustle | Gambling boys | Fake nurse | more
If all American voters were single-issue deciders and the cost of healthcare were their issue, Democrat candidates would win the mid-term elections handily. But loyalists of the donkey party shouldn’t be smug around their elephant counterparts.
Joint Commission partners with STS, ACC on new cardiac care certification
The new certification is focused on the importance of high-quality care and real-world patient outcomes. It will be based on the same data care teams already submit if they participate in the STS Adult Cardiac Surgery Database, ACC CathPCI Registry or STS/ACC TVT Registry.
Overconfident patients, underconfident nurses, pilot failures & more AI briefings
More than 75% of U.S. nurses have high hopes in generative AI’s promise for improving productivity. But less than half feel prepared to use it effectively.
Outspoken nurses in hot water | Population growth slowdown | Hospitals becoming Medicare Advantage carriers | and more news & views of note
How politically heated is the present moment? Enough to elicit verbal violence from trusted nurses.
Faster treatments, better outcomes: 5 key takeaways from new stroke guideline
The American Stroke Association's first major update in 7 years highlights the importance of coordinated care and expands patient access to critical treatments. It also includes the first detailed recommendations for treating stroke in pediatric patients.

Newsweek ranked the 50 best heart hospitals in the world

Young SAVR patients live longer with mechanical valves—should surgeons, cardiologists rethink current practice?

Bioprosthetic valves are being used more and more for aortic valve replacement, but mechanical valves appear to provide better long-term outcomes for patients 60 and younger. The new study, based on data from nearly 110,000 patients, was presented at STS 2025 and published in the Journal of the American College of Cardiology.

Cardiologists in Spain encountered an unexpected complication in a 78-year-old transcatheter aortic valve replacement (TAVR) patient, highlighting the experience in JACC: Cardiovascular Interventions.

TAVR valve’s spontaneous leaflet rupture highlights importance of long-term follow-up

Cardiologists believe this is the first time this exact complication has been reported. Even patients who present with no known risk factors, they said, should receive regular follow-up care to ensure such incidents do not go untreated.

Heart transplant patients on Medicaid face a higher risk of major complications

In addition, researchers noted, five-year mortality was inferior for patients on Medicaid when compared to patients with any other type of insurance.

Industry Watcher’s Digest

When Larry Ellison talks about healthcare AI, people invest. At least, that’s what happened after the Oracle chairman enthused over AI’s potential to cook up vaccines for cancer.

Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.

ACC.24 sign American College of Cardiology

American College of Cardiology announces late-breaking clinical trials for ACC.25

The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.

Industry Watcher’s Digest

What is Stargate and why is it here?

Care Delivery

Briefly: Democrats winning on healthcare | Hospital pharmacies blinded by bustle | Gambling boys | Fake nurse | more

Joint Commission partners with STS, ACC on new cardiac care certification

Overconfident patients, underconfident nurses, pilot failures & more AI briefings

Outspoken nurses in hot water | Population growth slowdown | Hospitals becoming Medicare Advantage carriers | and more news & views of note

Faster treatments, better outcomes: 5 key takeaways from new stroke guideline